🔎 Trials Near Me

Hem › Sickelcellssjukdom › District of Columbia › Washington

Kliniska studier för Sickelcellssjukdom i Washington, DC

20 studier för Sickelcellssjukdom söker deltagare vid platser i och runt Washington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

RekryterarObservationsstudieFriska volontärer välkomna
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 18 till 70 · Alla kön · Uppdaterad 2 okt. 2026 · NCT03937817

Blood Sampling for Research Related to Sickle Cell Disease

RekryterarObservationsstudieFriska volontärer välkomna
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 18 till 100 · Alla kön · Uppdaterad 29 sep. 2026 · NCT00542230

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

RekryterarTidig fas 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 18 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06313398

Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

RekryterarObservationsstudie
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 18 till 120 · Alla kön · Uppdaterad 18 sep. 2026 · NCT05170412

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

RekryterarFas 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 18 till 65 · Alla kön · Uppdaterad 17 sep. 2026 · NCT05904093

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

RekryterarFas 3
  • Childrens National Medical Ctr, Washington D.C.
  • MedStar Hlth Res Institute, Washington D.C.
Ålder 12 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06612268

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

RekryterarObservationsstudie
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 2 till 99 · Alla kön · Uppdaterad 11 sep. 2026 · NCT06944067

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

RekryterarFas 1
  • National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda · 7 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06442761

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

RekryterarFas 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 4 till 65 · Alla kön · Uppdaterad 4 sep. 2026 · NCT07599176

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

RekryterarFas 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 18 till 90 · Alla kön · Uppdaterad 24 aug. 2026 · NCT07566494

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

RekryterarObservationsstudie
  • Georgetown University, Washington D.C.
  • Children's National Hemophilia Center, Washington D.C.
Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT04398628

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

RekryterarFas 2
  • Center for Cancer and Blood Disorders, Bethesda · 7 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT07224360

Cooperative Assessment of Late Effects for SCD Curative Therapies

RekryterarObservationsstudie
  • Children's National Medical Center, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Ålder 4 till 65 · Alla kön · Uppdaterad 27 juli 2026 · NCT05153967

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

RekryterarObservationsstudie
  • Children's National Hospital (MRD-HCT), Washington D.C.
Ålder 3 till 20 · Alla kön · Uppdaterad 4 juni 2026 · NCT06941389

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

RekryterarFas 2
  • Children's National Hospital, Washington D.C.
Ålder 4 till 21 · Alla kön · Uppdaterad 13 apr. 2026 · NCT06635902

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

RekryterarFas 2
  • Children's National Health System, Washington D.C.
Ålder 2 till 25 · Alla kön · Uppdaterad 10 mars 2026 · NCT03587272

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

RekryterarFas 2
  • Children's National Hospital, Washington D.C.
Ålder 2 till 25 · Alla kön · Uppdaterad 26 sep. 2025 · NCT06358638

Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease

Rekryterar
  • Children's National Hospital, Washington D.C.
Ålder 7 till 16 · Alla kön · Uppdaterad 13 feb. 2025 · NCT06770010

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

Rekryterar
  • Children's National Hospital, Washington D.C.
Ålder 8 till 16 · Alla kön · Uppdaterad 10 jan. 2025 · NCT05099874

Sickelcellssjukdom-studier i andra städer

Andra studier i Washington

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.